Patients were diagnosed with ANCA-related HP or OMAVV if serum MPO–ANCA and/or PR3-ANCA titers were elevated or if ANCA-related disease (such as GPA, MPA or EGPA) co-occurred with HP or OM. This evidence concerns the gene PRTN3 and ocular melanoma.